In the context of CMTs, biomarkers such as mucin 1 (MUC1), cytokeratins 8 and 18 (CK8/18) and Kiel 67 (Ki-67) are essential for confirming the epithelial origin of the tumour cells and evaluating their proliferative potential (15). The gene discussed is MUC1; the disease is neoplasm.